Mitchell Sinkler & Starr Becton Dickinson & CO Transaction History

Mitchell Sinkler & Starr

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$254.9 - $283.59 $8,156 - $9,074	-32 Reduced 3.31%	934 $241,000
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $221,899 - $250,532	966 New	966 $239,000
Q1 2022 Apr 19, 2022	SELL	$243.64 - $270.48 $730 - $811	-3 Reduced 0.32%	926 $246,000
Q4 2021 Feb 01, 2022	SELL	$230.08 - $250.94 $10,583 - $11,543	-46 Reduced 4.72%	929 $234,000
Q2 2021 Jul 15, 2021	SELL	$232.65 - $254.58 $20,938 - $22,912	-90 Reduced 8.45%	975 $237,000
Q1 2021 Apr 12, 2021	BUY	$232.09 - $256.88 $247,175 - $273,577	1,065 New	1,065 $259,000
Q1 2020 Apr 07, 2020	SELL	$195.69 - $279.01 $144,614 - $206,188	-739 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$236.45 - $266.82 $174,736 - $197,179	739 New	739 $201,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

Stay updated on Mitchell Sinkler & Starr with notifications on news.